2024-02-26T12:37:48-05:00 2024-01-31 410941592 MAIR & ASSOCIATES PLLP 3570 LEXINGTON AVE N STE 300 SAINT PAUL MN 55126 990EZ 2023-02-01 824257211 THE ISTHMUS FOUNDATION ISTH 9523007176 10141 IRWIN RD MINNEAPOLIS MN 55437 ROSS DUNBAR EXECUTIVE DIRECTOR 9523007176 2024-02-17 ROSS DUNBAR 999009999 false BRUCE S MAIR P00204666 6514821698 2024-02-26 2023 2023-04-26 12:10:37Z X WWW.ISTHMUSFOUNDATION.ORG X X 80250 X 80250 80250 21000 14496 60634 96130 -15880 16954 1074 16954 1074 16954 1074 16954 1074 X THE ISTHMUS FOUNDATION (TIF) IS A NON-PROFIT ORGANIZATION DEDICATED TO TRANSFORMING STEM CELL DISCOVERIES INTO CURES FOR UNMET MEDICAL NEEDS. THROUGH OUR ALLIANCES WE BRIDGE THE GAP BETWEEN ACADEMIC AND SCIENTIFIC RESEARCH AND THE DEVELOPMENT AND DELIVERY OF MORE EFFECTIVE PATIENT THERAPIES. OUR ADVOCACY AND PASSION LEVERAGE REGIONAL AND GLOBAL RESOURCES, PARTNERSHIPS, AND FUNDS TO ADVANCE PROMISING STEM CELL SCIENCE FOR HUMAN HEALTH. STEM CELLS ARE POWERFUL BECAUSE OF THEIR VERSATILITY. THE ABILITY TO DIFFERENTIATE INTO OTHER CELL TYPES, TO REPAIR AND MODIFY INJURED AND DISEASED TISSUE AND BE MANUFACTURED AND DELIVERED AS CLINICAL PRODUCTS HOLDS THE PROMISE FOR DEVELOPING NEW TREATMENTS AND CURES FOR A WIDE RANGE OF CONDITIONS SUCH AS CANCER, DIABETES, HEART DISEASE & NEUROLOGICAL. THE ISTHMUS FOUNDATIONS APPROACH TO ACCELERATING THE TRANSLATION OF STEM CELL THERAPIES IS HIGHLY COLLABORATIVE, INVOLVING AN EVER-EXPANDING NETWORK OF SCIENTISTS, CLINICIANS, INVESTORS, BUSINESSES, HEALTHCARE PROVIDERS, AND MANUFACTURING EXPERTS THAT HAVE THE COLLECTIVE RESOURCES TO TRANSLATE STEM CELL ADVANCEMENTS INTO THERAPIES AND PRODUCTS. THESE RELATIONSHIPS ALLOW ISTHMUS TO DEVELOP AND MATURE THE VALUE OF EMERGING STEM CELL TECHNOLOGIES TO LAUNCH THE NEXT WAVE OF COMPANIES THAT WILL CHANGE THE LIVES OF PATIENTS AND THEIR FAMILIES, WORLDWIDE. WE ADVANCE SUPPORTED CANDIDATE RESEARCH THROUGH THE APPLICATION OF WORLD CLASS PROJECT MANAGEMENT AND STRATEGIC BUSINESS DEVELOPMENT IN THREE STAGES: 1. IDENTIFY 2. INNOVATE 3. IMPLEMENT 82941 82941 ROSS DUNBAR EXECUTIVE DI 12.00 21000 JAMES DUTTON VICE CHAIR 3.00 0 MICHAEL OKERLUND SECRETARY 0.50 0 STEVE WOLD RETIRED VP/C 0.50 0 false false false false false false false false false MN ROSS DUNBAR 10141 IRWIN RD MINNEAPOLIS MN 55437 9523007176 false false false false false false false false false false false NONE NONE true X 18000 32030 23331 84072 80250 237683 18000 32030 23331 84072 80250 237683 5582 322 5000 10904 5582 322 5000 10904 226779 18000 32030 23331 84072 80250 237683 0.95410 1.00000 0.00000 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990-EZ, PART I, LINE 16 EXPENSES TRAVEL 97 MEALS 473 SUB CONTRACTORS 26,202 MATERIALS/ENGINEERING 28,449 MN ATTORNEY GENERAL 25 BANK FEES 8 REGISTRATION FEES 155 MARKET RESEARCH 225 DONATION 5,000 TOTAL 60,634 FORM 990-EZ, PART III THE ISTHMUS FOUNDATION (TIF) IS A NON-PROFIT ORGANIZATION DEDICATED TO TRANSFORMING STEM CELL DISCOVERIES INTO CURES FOR UNMET MEDICAL NEEDS. THROUGH OUR ALLIANCES WE BRIDGE THE GAP BETWEEN ACADEMIC AND SCIENTIFIC RESEARCH AND THE DEVELOPMENT AND DELIVERY OF MORE EFFECTIVE PATIENT THERAPIES. OUR ADVOCACY AND PASSION LEVERAGE REGIONAL AND GLOBAL RESOURCES, PARTNERSHIPS, AND FUNDS TO ADVANCE PROMISING STEM CELL SCIENCE FOR HUMAN HEALTH. STEM CELLS ARE POWERFUL BECAUSE OF THEIR VERSATILITY. THE ABILITY TO DIFFERENTIATE INTO OTHER CELL TYPES, TO REPAIR AND MODIFY INJURED AND DISEASED TISSUE AND BE MANUFACTURED AND DELIVERED AS CLINICAL PRODUCTS HOLDS THE PROMISE FOR DEVELOPING NEW TREATMENTS AND CURES FOR A WIDE RANGE OF CONDITIONS SUCH AS CANCER, DIABETES, HEART DISEASE & NEUROLOGICAL. FORM 990-EZ, PART III, LINE 28 THE ISTHMUS FOUNDATIONS APPROACH TO ACCELERATING THE TRANSLATION OF STEM CELL THERAPIES IS HIGHLY COLLABORATIVE, INVOLVING AN EVER-EXPANDING NETWORK OF SCIENTISTS, CLINICIANS, INVESTORS, BUSINESSES, HEALTHCARE PROVIDERS, AND MANUFACTURING EXPERTS THAT HAVE THE COLLECTIVE RESOURCES TO TRANSLATE STEM CELL ADVANCEMENTS INTO THERAPIES AND PRODUCTS. THESE RELATIONSHIPS ALLOW ISTHMUS TO DEVELOP AND MATURE THE VALUE OF EMERGING STEM CELL TECHNOLOGIES TO LAUNCH THE NEXT WAVE OF COMPANIES THAT WILL CHANGE THE LIVES OF PATIENTS AND THEIR FAMILIES, WORLDWIDE. WE ADVANCE SUPPORTED CANDIDATE RESEARCH THROUGH THE APPLICATION OF WORLD CLASS PROJECT MANAGEMENT AND STRATEGIC BUSINESS DEVELOPMENT IN THREE STAGES: 1. IDENTIFY 2. INNOVATE 3. IMPLEMENT